Bio-active Peptide Market Projected to Reach US$ 4,191.8 Million by 2033

It is anticipated that the global market for bio-active peptides will expand significantly, rising from US$ 2,508 million in 2023 to US$ 4,191.8 million in 2033, with a noteworthy compound yearly growth rate (CAGR) of 5.3% during the forecast period.

Unleash Your Potential Now! Get Your Custom Report and Make Informed Choices for Better Decision-Making! https://www.futuremarketinsights.com/reports/sample/rep-gb-17708

The market for bioactive peptides is expanding as diet-based medical therapies become more prevalent.

As a result, the increased prevalence of chronic diseases like cancer and the rising demand for protein-based diets are important factors that are anticipated to support the growth of the bioactive pharmaceuticals market from 2023 to 2033.

Additionally, the substantial rise in commercial applications brought on by the advantages of these pills, together with continuous research and advancements, are likely to favorably affect the development of the bioactive pills market.

Also anticipated to provide a number of growth opportunities for the bioactive peptid market during the forecast period are accelerating technological innovations and advancements in bioactive peptide extraction techniques from natural sources, as well as an increase in the use of these products in pharmaceuticals, dietary supplements, and food products.

For instance, peptide supplementation has a double effect on bone formation, according to a recent study by the French National Institute for Agronomic Research. This is significant because supplements are frequently promoted as helping with bone growth.

According to this study, peptides concentrate on bone-targeting cells and are an effective nutritional intervention to improve bone health.

The growing older population worldwide, as well as increased concerns about bone health due to a variety of bone health disorders, are projected to drive the growth of the global bioactive peptide market.

-Key Takeaways from the Bio-active Peptide Report:

-The market is estimated to reach a valuation of US$ 2,508.3 million in 2023.
-Global demand registered a CAGR of 5.0% historically from 2018 to 2022.
-Global demand for bio-active peptides is expected to increase at a CAGR of around 5.3% through 2033.
-Based on the source, demand for plant-based bioactive peptides is expected to continue as it is holding a market share of 34.0% to reach a market valuation of US$ 1,425.0 million by the end of 2033.
-According to FMI analysis, the liquid segment is predicted to attain a market share of 78.0% during the assessment period, resulting in a market size of US$ 1,610.7 million by 2033.
-According to FMI, the United States is expected to reach a valuation of US$ 1,509.0 million by 2033.

Top 10 Bio-active Peptide manufacturers listed in the report:

1. Angel Yeast Co., Ltd.

2. BASF SE

3. Seagarden AS

4. Archer Daniels Midland Company

5. Ingredia SA

6. Rousselot S.A.S.

7. FrieslandCampina Ingredients

8. Peptan

9. Kerry Group plc

10. CP Kelco USA, Inc.

These companies are expanding product portfolios, employing strategies like advertising, partnerships, acquisitions, agreements, and mergers to maintain market relevance and drive growth in the Bio-active Peptide market.

For instance,

• In November 2021, the Caribbean Agricultural Research and Development Institute (CARDI) and The United Nations Food and Agriculture Organisation (FAO) recently collaborated to offer a virtual Bio-active Peptide for Animal Feed Seminar for stakeholders and 25 participants.

• In 2021, Nuritas, based in Ireland, announced a multi-year collaboration agreement with Japan's Sumitomo Chemical Co Ltd to develop bioactive peptides.

In February 2023, the study, published in the Journal of Nutrition, indicated that the bioactive peptides outperform typical animal proteins, notably milk protein, in muscle training.
In 2018, Nuritas and Nestlé announced a partnership to find food-derived 'bioactive peptide' networks.

Obtain complete access to the comprehensive report featuring the most recent insights:
https://www.futuremarketinsights.com/reports/bio-active-peptide-market

Get More Valuable Insights

Future Market Insights (FMI), in its new offering, provides an unbiased analysis of the global Bio-active Peptide market presenting historical demand data (2018 to 2022) and forecast statistics for the period from 2023 to 2033.

The study incorporates compelling insights on the Bio-active Peptide market based on Source(Plant, Animal, and Marine) Type (Milk Peptides, Egg Peptides, Soy Peptides, Marine Peptides, Meat Peptides, and Others), Form (Liquid, Powder, and Capsule), Application (Functional Food, Dietary Supplements, Pharmaceuticals, Animal Feed, and Others), across various regions.

-Bio-active Peptide Market by Category

-By Type:
Milk Peptides
Egg Peptides
Soy Peptides
Marine Peptides
Meat Peptides
Others

-By Source:
Plant
Animal
Marine

-By Application:
Functional Food
Dietary Supplements
Pharmaceuticals
Animal Feed
Others

-By Form:
Liquid
Powder
Capsule

-By Region:
North America
Europe
Latin America
East Asia
Oceania
South Asia
Middle East & Africa

Contact Us:
Nandini Singh Sawlani
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

This release was published on openPR.